Chung Chiang Hsu

Part of Lifemax Healthcare International Corp., LifeMax Laboratories, Inc. is a clinical-stage biotech company based in Redwood City, CA. The company focuses on treating orphan diseases with few or no therapeutic options by developing and commercializing first-in-class assets that target the underlying genetic abnormality and address critical unmet medical needs. The company was founded by Laura Zhu and Chung Chiang Hsu, with Chung Chiang Hsu serving as CEO since incorporation.

Lifemax Healthcare International Corp. manufactures and sells pharmaceutical and biotech products. The company was founded by Chung Chiang Hsu, Laura Zhu and Ann Hsu in 2014 and is headquartered in Redwood City, CA.

AmMax Bio, Inc. is a clinical stage biotech company. The private company is based in Redwood City, CA. The CEO of the company is Chung Chiang Hsu.

AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then.

Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ.

Impax Pharmaceuticals, Inc. is an drug delivery company, which develops, manufactures and markets prescription pharmaceutical products. It is located in Hayward, CA.

Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA.